Thalys Medical Technology Group Inc
SSE:603716
Thalys Medical Technology Group Inc
Operating Expenses
Thalys Medical Technology Group Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Thalys Medical Technology Group Inc
SSE:603716
|
Operating Expenses
-¥452.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Operating Expenses
-¥23.5B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Expenses
-¥6.5B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Expenses
-¥3.1B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Expenses
-¥4.8B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-30%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Expenses
-¥458.8m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
See Also
What is Thalys Medical Technology Group Inc's Operating Expenses?
Operating Expenses
-452.2m
CNY
Based on the financial report for Sep 30, 2023, Thalys Medical Technology Group Inc's Operating Expenses amounts to -452.2m CNY.
What is Thalys Medical Technology Group Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-17%
Over the last year, the Operating Expenses growth was 4%. The average annual Operating Expenses growth rates for Thalys Medical Technology Group Inc have been -13% over the past three years , -17% over the past five years .